Arbutus Biopharma Corporation (ABUS) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arbutus Biopharma Corpora...

    NASDAQ: ABUS · Real-Time Price · USD
    4.38
    -0.11 (-2.45%)
    At close: Oct 03, 2025, 3:59 PM
    4.47
    2.05%
    After-hours: Oct 03, 2025, 07:48 PM EDT

    Arbutus Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 36.33M 26.29M 30.78M 109.28M
    Short-Term Investments
    		 86.29M 99.72M 116.14M 46.03M
    Long-Term Investments
    		 n/a 6.28M 37.36M 35.69M
    Other Long-Term Assets
    		 34K n/a 103K 61K
    Receivables
    		 2.41M 1.78M 1.35M 899K
    Inventory
    		 n/a n/a -2.87M -4.45M
    Other Current Assets
    		 2.28M 4.25M 2.87M 4.45M
    Total Current Assets
    		 127.32M 132.03M 151.14M 160.66M
    Property-Plant & Equipment
    		 4.36M 6.09M 6.81M 8.07M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.39M 12.37M 44.28M 43.82M
    Total Assets
    		 131.71M 144.4M 195.42M 204.49M
    Account Payables
    		 2.32M 3.22M 3.52M 3.17M
    Deferred Revenue
    		 7.57M 11.79M 16.46M 7.64M
    Short-Term Debt
    		 483K n/a 372K 383K
    Other Current Liabilities
    		 1.85M 3.7M 16.81M -383K
    Total Current Liabilities
    		 15.62M 22.49M 32.86M 11.22M
    Long-Term Debt
    		 n/a 6.95M n/a n/a
    Other Long-Term Liabilities
    		 15.05M 7.6M 17.9M 21.59M
    Total Long-Term Liabilities
    		 18.72M 15.9M 25.71M 23.82M
    Total Liabilities
    		 34.34M 38.38M 58.57M 35.05M
    Total Debt
    		 1.29M 8.72M 2.19M 2.61M
    Book Value
    		 97.37M 106.02M 136.85M 169.44M
    Book Value Per Share
    		 0.52 0.64 0.91 1.59
    Common Stock
    		 1.41B 1.35B 1.32B 1.29B
    Retained Earnings
    		 -1.35B -1.28B -1.2B -1.13B
    Comprehensive Income
    		 -48.13M -48.42M -50.49M -48.34M
    Shareholders Equity
    		 97.37M 106.02M 136.85M 169.44M
    Total Investments
    		 86.29M 106M 153.5M 81.72M

    Add to Watchlist